Health Care

Targeted Stocks: Geron Corporation (NASDAQ:GERN), Organovo Holdings, Inc. (NYSEMKT:ONVO)

0 111

Geron Corporation (NASDAQ:GERN) went lower by -2.22% to close at $ 2.64. The company exchanged total volume of 1.43 million shares throughout course of last trade however it holds an average trading capacity of 1.77 million shares. Shares of company began trading at $2.77 climbed to high of $2.77 touched the low of $2.63.

The company is trading below its 50-day moving averages of 2.77 and down from 200-day moving averages of 2.99. The firm has price to book ratio of 3.14 and its price to sale ratio was 11.73.

Geron Corporation (GERN) reported the recent issuance of three U.S. patents related to the company’s telomerase inhibitor, imetelstat.

The first patent, U.S. 9,375,485, has claims covering the use of telomerase inhibitor compounds, including imetelstat, for alleviating at least one symptom of myelofibrosis or myelodysplastic syndromes, including chronic myelomonocytic leukemia. This patent is predictable to remain in force until at least March 2033. The other two patents, U.S. 9,388,415 and U.S. 9,388,416, have claims covering methods for using imetelstat to inhibit the activity of telomerase and using imetelstat to inhibit cancer cell proliferation, as well as methods for using imetelstat to treat cancer, and are predictable to remain in force until at least September 2024.

Geron Corporation’s (GERN) has price-to-cash ratio of 3.83 and price to sale ratio of 11.46. The company net profit margin is 1.40% A look on the firm performance, its monthly performance is -2.58% and a quarterly performance of -17.50%. The stock price is moving down from its 20 days moving average with -1.57% and isolated negatively from 50 days moving average with -4.81%.

Brokerage Recommendations:

According to ZACKS data, different Brokerage Firms rated the stock about their BUY, SELL or HOLD recommendations. 2 Months Ago, shares have been suggested as “BUY” from “1” brokerage firms and recommended as “Strong Buy” by “0” brokerage firms. 0” brokerage firms have issued “Sell” rating for the company and “Strong Sell” rating was issued by “1.5” brokerage firms. “0” brokerage firms have rated the company as a “Hold”. The Corporation has average brokerage recommendation (ABR) of 0 based on consensus of the brokerage firms issuing ratings.

Organovo Holdings, Inc. (NYSEMKT:ONVO) dropped -1.30% and closed the trade at $ 3.80. The company recorded a trading capacity of 1.18 million shares above its three months average daily volume of 827.24 thousand shares. During the last trade, shares reached to high price of $3.95 and touched the low price of $3.75. The stock’s 50-day moving average is noted at $3.29 and its 200-day moving average is stands at $2.55.

Additionally, the company has EPS of -0.43. The company has market capitalization of $351.09M.

The average true range of Organovo Holdings, Inc.’s (ONVO) is recorded at 0.25 and the relative strength index of the stock stands 61.77. The stock price is going above to its 52 week low with 137.50% and lagging behind from its 52 week high with -12.64%. Analyst recommendation for this stock stands at 1.50. A look on the firm performance, its monthly performance is 31.49% and a quarterly performance of 52.00%. The stock price is trading upbeat from its 200 days moving average with 40.57% and up from 50 days moving average with 24.61%.

Brokerage Recommendations:

According to ZACKS data, different Brokerage Firms rated the stock about their BUY, SELL or HOLD recommendations. 2 Months Ago, shares have been suggested as “BUY” from “1” brokerage firms and recommended as “Strong Buy” by “0” brokerage firms. 0” brokerage firms have issued “Sell” rating for the company and “Strong Sell” rating was issued by “1.67” brokerage firms. “0” brokerage firms have rated the company as a “Hold”. The Corporation has average brokerage recommendation (ABR) of 0 based on consensus of the brokerage firms issuing ratings.

 

 

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

Advirtisement

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter